National Academies Press: OpenBook

A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report (2017)

Chapter: Appendix C: Public Meeting Agenda

« Previous: Appendix B: Modeling the Elimination of Hepatitis C in the United States
Suggested Citation:"Appendix C: Public Meeting Agenda." National Academies of Sciences, Engineering, and Medicine. 2017. A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report. Washington, DC: The National Academies Press. doi: 10.17226/24731.
×

Appendix C

Public Meeting Agenda

COMMITTEE ON A NATIONAL STRATEGY FOR THE ELIMINATION OF HEPATITIS B AND C

National Academy of Sciences Building, 2100 Constitution Avenue NW
Washington, DC 20001

June 8, 2016
Room 120

PHASE TWO ORIENTATION

9:00-9:15 Welcome and Introductions
Brian Strom, Committee Chair
9:15-10:15 Sponsor Orientation to Phase Two
John Ward, Director, Division of Viral Hepatitis, Centers for Disease Control and Prevention (CDC)
Nadine Gracia, Deputy Assistant Secretary for Minority Health, Office of Minority Health, Department of Health and Human Services (HHS)
Michael Fried, Board Member, American Association for the Study of Liver Diseases
Ryan Clary, Executive Director, National Viral Hepatitis Roundtable
10:15-10:30 Break
Suggested Citation:"Appendix C: Public Meeting Agenda." National Academies of Sciences, Engineering, and Medicine. 2017. A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report. Washington, DC: The National Academies Press. doi: 10.17226/24731.
×

SCREENING AND REFERRALS TO CARE

10:30-12:00 Panel Discussion on Novel Strategies for Testing and Follow-Up
Kathleen Maurer, Moderator
  • Sabrina Assoumou, Assistant Professor of Medicine, Boston University
  • Alicia Ifkovic-Mau, Correctional Counselor Supervisor, Department of Corrections, State of Connecticut
  • William Stauffer, Professor of Medicine and Pediatrics, Division of Infectious Diseases and International Medicine, University of Minnesota
  • David Thomas, Director, Division of Infectious Diseases, Johns Hopkins School of Medicine
12:00-1:00 Lunch

INNOVATIVE FINANCING FOR HEPATITIS C TREATMENTS

1:00-2:30 Panel Discussion on Paying for Cures
Neeraj Sood, Moderator
  • Tim Gronniger, Deputy Chief of Staff, Centers for Medicare & Medicaid Services
  • Steve Miller, Chief Medical Officer, Express Scripts
  • Coy Stout, Vice President, Managed Markets, Gilead
2:30-2:45 Break
2:45-4:15 Panel Discussion on Hepatitis C Treatment in Government Programs
Brian Strom, Moderator
  • John Coster, Director, Division of Pharmacy, Center for Medicaid and Children’s Health Insurance Program (CHIP) Services, Centers for Medicare & Medicaid Services
  • Kimberley Lenz, Clinical Pharmacy Manager, MassHealth
  • Robert Zavoski, Medical Director, Connecticut Department of Social Services
Suggested Citation:"Appendix C: Public Meeting Agenda." National Academies of Sciences, Engineering, and Medicine. 2017. A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report. Washington, DC: The National Academies Press. doi: 10.17226/24731.
×
4:15-4:45 Public Health and Drug Pricing: Policy Solutions for Population Coverage
Joshua Sharfstein, Professor of the Practice, Johns Hopkins Bloomberg School of Public Health
5:00 Adjourn
6:30 Working dinner for committee and staff at Circle Bistro

June 9, 2016
Members’ Room

INTERNATIONAL PROGRAMS ON VIRAL HEPATITIS

9:00-9:05 Welcome
Brian Strom, Committee Chair
9:05-9:35 Global Momentum for Viral Hepatitis Elimination
Stefan Wiktor, Team Lead, Global Hepatitis Program, World Health Organization (WHO)
9:40-10:10 An Australian Perspective on Hepatitis Elimination
Ben Cowie, Director, WHO Collaborating Centre for Viral Hepatitis, The Doherty Institute, University of Melbourne
10:10-10:30 Break

HARM REDUCTION AND NEEDLE EXCHANGE

10:30-12:00 Panel Discussion on Harm Reduction in Rural Areas and Small Towns
Shruti Mehta, Moderator
  • Jerome Adams, Health Commissioner, Indiana State Department of Health
  • Jennifer Havens, Associate Professor, Center for Drug and Alcohol Research, University of Kentucky College of Medicine
  • Robin Pollini, Senior Research Scientist, Pacific Institute for Research and Evaluation
12:00-1:00 Lunch
Suggested Citation:"Appendix C: Public Meeting Agenda." National Academies of Sciences, Engineering, and Medicine. 2017. A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report. Washington, DC: The National Academies Press. doi: 10.17226/24731.
×

INTEGRATING CLINICAL AND PUBLIC HEALTH DATA

1:00-2:30 Panel Discussion on Using Electronic Records for Clinical Medicine and Public Health
Grace Wang, Moderator
  • Jeff Duchin, Professor in Medicine, Division of Allergy and Infectious Diseases, University of Washington
  • Michael Klompas, Associate Professor and Infectious Diseases Specialist, Harvard Medical School and Harvard Pilgrim Health Care Institute
  • Chia Wang, Infectious Diseases Specialist and Clinical Associate Professor of Medicine, Virginia Mason Medical Center, International Community Health Services and University of Washington
Suggested Citation:"Appendix C: Public Meeting Agenda." National Academies of Sciences, Engineering, and Medicine. 2017. A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report. Washington, DC: The National Academies Press. doi: 10.17226/24731.
×
Page 267
Suggested Citation:"Appendix C: Public Meeting Agenda." National Academies of Sciences, Engineering, and Medicine. 2017. A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report. Washington, DC: The National Academies Press. doi: 10.17226/24731.
×
Page 268
Suggested Citation:"Appendix C: Public Meeting Agenda." National Academies of Sciences, Engineering, and Medicine. 2017. A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report. Washington, DC: The National Academies Press. doi: 10.17226/24731.
×
Page 269
Suggested Citation:"Appendix C: Public Meeting Agenda." National Academies of Sciences, Engineering, and Medicine. 2017. A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report. Washington, DC: The National Academies Press. doi: 10.17226/24731.
×
Page 270
Next: Appendix D: Committee Biographies »
A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report Get This Book
×
Buy Paperback | $76.00 Buy Ebook | $59.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world’s hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common types, surpassed HIV and AIDS to become the seventh leading cause of death worldwide.

The world now has the tools to prevent hepatitis B and cure hepatitis C. Perfect vaccination could eradicate HBV, but it would take two generations at least. In the meantime, there is no cure for the millions of people already infected. Conversely, there is no vaccine for HCV, but new direct-acting antivirals can cure 95 percent of chronic infections, though these drugs are unlikely to reach all chronically-infected people anytime soon. This report, the second of two, builds off the conclusions of the first report and outlines a strategy for hepatitis reduction over time and specific actions to achieve them.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!